FTC cows Sanofi into giving up on Maze licensing deal
Sanofi backed away from its drug-licensing deal with Maze Therapeutics after the Federal Trade Commission moved to block the deal.
Source: mmm-online.com
Stay updated with breaking news from Nate Soderstrom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanofi backed away from its drug-licensing deal with Maze Therapeutics after the Federal Trade Commission moved to block the deal.